BIP
APTO

Brandes Investment Partners’s Aptose Biosciences, Inc. APTO Stock Holding History

Brandes Investment Partners’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-94
Closed -$95K – 158
2017
Q4 		$95K Buy
+94
New +$72.7K ﹤0.01% 142

Other funds holding APTO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Brandes Investment Partners's APTO Position: Q1 2018 in Review

Brandes Investment Partners sold out of Aptose Biosciences, Inc. (APTO) in Q1 2018, closing a stake of 94 shares — an estimated $95K sold.

Brandes Investment Partners first reported a position in APTO in Q4 2017 and held it in 1 quarter. The position peaked at $95K in Q4 2017. 16 funds tracked by Wall St. Rank hold APTO as of Q1 2018.

  • Brandes Investment Partners reported no remaining Aptose Biosciences, Inc. position as of Q1 2018 after selling out during the quarter.
  • Brandes Investment Partners sold 94 Aptose Biosciences, Inc. shares in Q1 2018, an estimated $95K.
  • Brandes Investment Partners first reported a position in Aptose Biosciences, Inc. in Q4 2017 and held it in 1 quarter.
  • Brandes Investment Partners's Aptose Biosciences, Inc. position peaked at $95K in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2018.

Based on Brandes Investment Partners's 13F filing for Q1 2018, filed 15 May 2018.